<?xml version="1.0" encoding="UTF-8"?>
<ref id="B150-jcm-09-02084">
 <label>150.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Alattar</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ibrahim</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Shaar</surname>
    <given-names>S.H.</given-names>
   </name>
   <name>
    <surname>Abdalla</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Shukri</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Daghfal</surname>
    <given-names>J.N.</given-names>
   </name>
   <name>
    <surname>Khatib</surname>
    <given-names>M.Y.</given-names>
   </name>
   <name>
    <surname>Aboukamar</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Abukhattab</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Alsoub</surname>
    <given-names>H.A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Tocilizumab for the Treatment of Severe Coronavirus Disease 2019</article-title>
  <source>J. Med. Virol.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1002/jmv.25964</pub-id>
  <?supplied-pmid 32369191?>
  <pub-id pub-id-type="pmid">32369191</pub-id>
 </element-citation>
</ref>
